Shiva Ganjali

Dr. Shiva Ganjali


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
SGShiva Ganjali
Shiva Ganjali
AGAntonio M. Gotto
Antonio M. Gotto
MRMassimiliano Ruscica
Massimiliano Ruscica
SAStephen L Atkin
Stephen L Atkin
ABAlexandra E. Butler
Alexandra E. Butler
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar

1 January 2014 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
SGShiva Ganjali
Shiva Ganjali
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar
EMElahe Mahdipour
Elahe Mahdipour
KJKhadijeh Jamialahmadi
Khadijeh Jamialahmadi
STSepideh Torabi
Sepideh Torabi
MGMajid Ghayour-Mobarhan
Majid Ghayour-Mobarhan
Background. Obesity is a disorder often accompanied by a heightened state of systemic inflammation and immunoactivation. The present randomized crossover trial aimed to investigate the efficacy of curcumin, a bioactive polyphenol with established anti-inflammatory and immunomodulatory effects, on the serum levels of a panel of cytokines and mediators in obese individuals.Methods. Thirty obese individuals were randomized to receive curcumin at a daily dose of 1 g or a matched placebo for 4 weeks. Following a 2-week wash-out period, each group was assigned to the alternate treatment regimen for another 4 weeks. Serum samples were collected at the start and end of each study period. Serum levels of IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, VEGF, IFNγ, EGF, MCP-1, and TNFαwere measured using a multiplex Biochip Array Technology based method.Results. Mean serum IL-1β(P=0.042), IL-4 (P=0.008), and VEGF (P=0.01) were found to be significantly reduced by curcumin therapy. In contrast, no significant difference was observed in the concentrations of IL-2, IL-6, IL-8, IL-10, IFNγ, EGF, and MCP-1.Conclusions. The findings of the present trial suggested that curcumin may exert immunomodulatory effects via altering the circulating concentrations of IL-1β, IL-4, and VEGF.

17 March 2015 in Chinese Journal of Integrative Medicine
Verified
Journal Article
Closed access
PDF file
HEHabibollah Esmaily
Habibollah Esmaily
ASAmirhossein Sahebkar
Amirhossein Sahebkar
MIMehrdad Iranshahi
Mehrdad Iranshahi
SGShiva Ganjali
Shiva Ganjali
AMAkram Mohammadi
Akram Mohammadi
MGMajid Ghayour-Mobarhan
Majid Ghayour-Mobarhan

28 October 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
NFNarges Fereydouni
Narges Fereydouni
MDMajid Darroudi
Majid Darroudi
JMJebrail Movaffagh
Jebrail Movaffagh
ASAzadeh Shahroodi
Azadeh Shahroodi
ABAlexandra E. Butler
Alexandra E. Butler
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar

1 May 2017 in Pharmacological Research
Verified
Journal Article
Closed access
SGShiva Ganjali
Shiva Ganjali
CBChristopher N. Blesso
Christopher N. Blesso
Maciej BanachMaciej Banach
Maciej Banach
MPMatteo Pirro
Matteo Pirro
MMMuhammed Majeed
Muhammed Majeed
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar

6 June 2019 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YPYunes Panahi
Yunes Panahi
GVGhasem Valizadegan
Ghasem Valizadegan
NANobakht Ahamdi
Nobakht Ahamdi
SGShiva Ganjali
Shiva Ganjali
MMMuhammed Majeed
Muhammed Majeed
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar